NewAmsterdam Pharma Company NV (NASDAQ:NAMS)’s traded shares stood at 0.67 million during the last session, with the company’s beta value hitting -0.03. At the close
In the last trading session, 1.15 million NewAmsterdam Pharma Company NV (NASDAQ:NAMS) shares changed hands as the company’s beta touched -0.02. With the company’s per
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne